Table 1. Survival information and protein summary available in TRGAted.
Cancer Type | Samples | OS | DSS | DFI | PFI | Proteins |
---|---|---|---|---|---|---|
Adrenocortical carcinoma (ACC) | 46 | 46 | 46 | 28 | 46 | 221 |
Bladder Urothelial Carcinoma (BLCA) | 344 | 344 | 330 | 153 | 344 | 223 |
Breast invasive carcinoma (BRCA) | 901 | 873 | 855 | 750 | 873 | 224 |
Cervical squamous cell carcinoma
and endocervical adenocarcinoma (CESC) |
171 | 171 | 168 | 112 | 171 | 220 |
Cholangiocarcinoma (CHOL) | 30 | 30 | 29 | 21 | 30 | 219 |
Colon adenocarcinoma (COAD) | 358 | 325 | 311 | 126 | 325 | 223 |
Diffuse Large B-cell Lymphoma
(DLBCL) |
33 | 33 | 33 | 19 | 33 | 219 |
Esophageal carcinoma (ESCA) | 126 | 126 | 124 | 76 | 126 | 220 |
Glioblastoma multiforme (GBM) | 205 | 136 | 123 | 0 | 136 | 223 |
Head and Neck squamous cell
carcinoma (HNSC) |
346 | 346 | 326 | 85 | 346 | 239 |
Kidney Chromophobe (KICH) | 63 | 63 | 63 | 27 | 63 | 220 |
Kidney renal clear cell carcinoma
(KIRC) |
445 | 444 | 434 | 72 | 444 | 233 |
Kidney renal papillary cell carcinoma
(KIRP) |
208 | 207 | 205 | 127 | 207 | 221 |
Lower Grade Glioma (LGG) | 427 | 426 | 420 | 114 | 426 | 220 |
Liver hepatocellular carcinoma (LIHC) | 184 | 184 | 177 | 145 | 184 | 220 |
Lung adenocarcinoma (LUAD) | 362 | 361 | 327 | 203 | 361 | 239 |
Lung squamous cell carcinoma
(LUSC) |
325 | 325 | 295 | 210 | 325 | 239 |
Mesothelioma (MESO) | 61 | 61 | 45 | 10 | 61 | 220 |
Ovarian serous cystadenocarcinoma
(OV) |
411 | 405 | 377 | 199 | 407 | 224 |
Pancreatic adenocarcinoma (PAAD) | 105 | 105 | 99 | 40 | 105 | 221 |
Pheochromocytoma and
Paraganglioma (PCPG) |
81 | 79 | 79 | 71 | 79 | 220 |
Prostate adenocarcinoma (PRAD) | 351 | 351 | 350 | 233 | 351 | 220 |
Rectum adenocarcinoma (READ) | 130 | 126 | 120 | 31 | 126 | 223 |
Sarcoma (SARC) | 221 | 221 | 215 | 125 | 22 | 220 |
Skin Cutaneous Melanoma (SKCM) | 354 | 349 | 346 | 0 | 349 | 223 |
Stomach adenocarcinoma (STAD) | 392 | 357 | 334 | 207 | 357 | 220 |
Testicular Germ Cell Tumors (TGCT) | 118 | 104 | 104 | 79 | 104 | 219 |
Thyroid carcinoma (THCA) | 374 | 372 | 366 | 268 | 372 | 219 |
Thymoma (THYM) | 90 | 90 | 90 | 9 | 90 | 219 |
Uterine Corpus Endometrial
Carcinoma (UCEC) |
404 | 404 | 403 | 325 | 404 | 223 |
Uterine Carcinosarcoma (UCS) | 48 | 48 | 46 | 22 | 48 | 220 |
OS, overall survival; DSS, disease-specific survival; DFI, disease-free interval; PFI, progression-free interval.